16. Cervix cancer - The GEC-ESTRO Handbook of Brachytherapy

Cervix cancer

26

THE GEC ESTRO HANDBOOK OF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 01/09/2023

Figure 25. EMBRACE-I rectal morbidity: (A) overall prevalence and actuarial cumulative incidence (B) actuarial cumulative incidence for bleeding, proctitis, stenosis, fistula (Reprinted from Radiother. Oncol., 120/3, Mazeron R, Fokdal LU, Kirchheiner K, et al., Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study, 412-419, 2016, with permission from Elsevier).